Article

Blue light-filtering IOL option for cataract surgery

Anaheim, CA-Although longer follow-up is needed to determine whether the pseu-dophakic, blue light-filter-ing IOL (AcrySof Natural, Alcon) reduces the risk of progression of age-related macular degeneration (AMD), available indirect evidence provides sufficient sup-port to advocate its use in cataract surgery, said Robert J. Cionni, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.